These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15894067)

  • 1. Behavioral effects of the novel cannabinoid full agonist AM 411.
    McLaughlin PJ; Lu D; Winston KM; Thakur G; Swezey LA; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2005 May; 81(1):78-88. PubMed ID: 15894067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irt>t schedule controlled behavior in 'learned-helpless' rats: effects from a cannabinoid agonist.
    Willmore CB; Kohler GD; Makriyannis A
    Neuropharmacology; 2006 Jul; 51(1):90-101. PubMed ID: 16753187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054.
    McLaughlin PJ; Thakur GA; Vemuri VK; McClure ED; Brown CM; Winston KM; Wood JT; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2013 Aug; 109():16-22. PubMed ID: 23603029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387.
    McLaughlin PJ; Qian L; Wood JT; Wisniecki A; Winston KM; Swezey LA; Ishiwari K; Betz AJ; Pandarinathan L; Xu W; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2006 Mar; 83(3):396-402. PubMed ID: 16616951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
    Gorriti MA; Ferrer B; del Arco I; Bermúdez-Silva FJ; de Diego Y; Fernandez-Espejo E; Navarro M; Rodríguez de Fonseca F
    Pharmacol Biochem Behav; 2005 May; 81(1):71-7. PubMed ID: 15894066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Adamantyl-delta8-tetrahydrocannabinol (AM-411), a selective cannabinoid CB1 receptor agonist: effects on open-field behaviors and antagonism by SR-141716 in rats.
    Järbe TU; DiPatrizio NV; Lu D; Makriyannis A
    Behav Pharmacol; 2004 Nov; 15(7):517-21. PubMed ID: 15472574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
    Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
    Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2005 Jan; 55(1):1-16. PubMed ID: 15499609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
    Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
    Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system.
    Zarrindast MR; Sarahroodi S; Arzi A; Khodayar MJ; Taheri-Shalmani S; Rezayof A
    Behav Pharmacol; 2008 Oct; 19(7):716-23. PubMed ID: 18797248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
    Wilkinson JD; Williamson EM
    J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral pharmacological properties of a novel cannabinoid 1',1'-dithiolane delta8-THC analog, AMG-3.
    Antoniou K; Galanopoulos A; Vlachou S; Kourouli T; Nahmias V; Thermos K; Panagis G; Daifoti Z; Marselos M; Papahatjis D; Spyraki C
    Behav Pharmacol; 2005 Sep; 16(5-6):499-510. PubMed ID: 16148456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm.
    De Vry J; Jentzsch KR
    Behav Pharmacol; 2003 Sep; 14(5-6):471-6. PubMed ID: 14501260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists.
    McLaughlin PJ; Winston KM; Swezey LA; Vemuri VK; Makriyannis A; Salamone JD
    Pharmacol Biochem Behav; 2010 Jul; 96(1):75-81. PubMed ID: 20403373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1 receptor knockout mice show similar behavioral modifications to wild-type mice when enkephalin catabolism is inhibited.
    Jardinaud F; Crété D; Canestrelli C; Ledent C; Roques BP; Noble F
    Brain Res; 2005 Nov; 1063(1):77-83. PubMed ID: 16256959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats.
    McLaughlin PJ; Brown CM; Winston KM; Thakur G; Lu D; Makriyannis A; Salamone JD
    Behav Pharmacol; 2005 Sep; 16(5-6):477-86. PubMed ID: 16148454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a novel CB1 agonist on visual attention in male rats: role of strategy and expectancy in task accuracy.
    Miller RL; Thakur GA; Stewart WN; Bow JP; Bajaj S; Makriyannis A; McLaughlin PJ
    Exp Clin Psychopharmacol; 2013 Oct; 21(5):416-25. PubMed ID: 24099361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.
    Sink KS; McLaughlin PJ; Wood JA; Brown C; Fan P; Vemuri VK; Peng Y; Olszewska T; Thakur GA; Makriyannis A; Parker LA; Salamone JD
    Neuropsychopharmacology; 2008 Mar; 33(4):946-55. PubMed ID: 17581535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel adamantyl cannabinoids as CB1 receptor probes.
    Thakur GA; Bajaj S; Paronis C; Peng Y; Bowman AL; Barak LS; Caron MG; Parrish D; Deschamps JR; Makriyannis A
    J Med Chem; 2013 May; 56(10):3904-21. PubMed ID: 23621789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.